skip to main content

    Updated Visitor Guidelines

 

MENU

 

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers

This trial is no longer accepting participants. To get information / assistance on finding a clinical trial that is right for you, please call 800-865-1125.